A Phase 1, Open-label, Parallel-group Study to Evaluate the Single-dose Pharmacokinetics of Sotagliflozin in Male and Female Subjects With Mild, Moderate, and Severe Hepatic Impairment and Matched Subjects With Normal Hepatic Function
Phase of Trial: Phase I
Latest Information Update: 21 Nov 2016
At a glance
- Drugs Sotagliflozin (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Lexicon Pharmaceuticals
- 15 Nov 2016 Status changed from active, no longer recruiting to completed.
- 31 Dec 2015 According to ClinicalTrials.gov record, status changed from recruiting to active, no longer recruiting.
- 21 Aug 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.